JP2021152544A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021152544A5 JP2021152544A5 JP2021092988A JP2021092988A JP2021152544A5 JP 2021152544 A5 JP2021152544 A5 JP 2021152544A5 JP 2021092988 A JP2021092988 A JP 2021092988A JP 2021092988 A JP2021092988 A JP 2021092988A JP 2021152544 A5 JP2021152544 A5 JP 2021152544A5
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- antibody
- subunit
- monospecific antibody
- monospecific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022139802A JP2022171730A (ja) | 2015-05-12 | 2022-09-02 | 多量体タンパク質の純度の決定 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562160341P | 2015-05-12 | 2015-05-12 | |
| US62/160,341 | 2015-05-12 | ||
| JP2017558949A JP7240812B2 (ja) | 2015-05-12 | 2016-05-11 | 多量体タンパク質の純度の決定 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017558949A Division JP7240812B2 (ja) | 2015-05-12 | 2016-05-11 | 多量体タンパク質の純度の決定 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022139802A Division JP2022171730A (ja) | 2015-05-12 | 2022-09-02 | 多量体タンパク質の純度の決定 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021152544A JP2021152544A (ja) | 2021-09-30 |
| JP2021152544A6 JP2021152544A6 (ja) | 2021-11-11 |
| JP2021152544A5 true JP2021152544A5 (cg-RX-API-DMAC7.html) | 2022-06-30 |
| JP7137663B2 JP7137663B2 (ja) | 2022-09-14 |
Family
ID=56072452
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017558949A Active JP7240812B2 (ja) | 2015-05-12 | 2016-05-11 | 多量体タンパク質の純度の決定 |
| JP2021092988A Expired - Fee Related JP7137663B2 (ja) | 2015-05-12 | 2021-06-02 | 多量体タンパク質の純度の決定 |
| JP2022139802A Pending JP2022171730A (ja) | 2015-05-12 | 2022-09-02 | 多量体タンパク質の純度の決定 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017558949A Active JP7240812B2 (ja) | 2015-05-12 | 2016-05-11 | 多量体タンパク質の純度の決定 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022139802A Pending JP2022171730A (ja) | 2015-05-12 | 2022-09-02 | 多量体タンパク質の純度の決定 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10520511B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3294775B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7240812B2 (cg-RX-API-DMAC7.html) |
| AR (1) | AR104610A1 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2016261854B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2984010A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2881359T3 (cg-RX-API-DMAC7.html) |
| MA (2) | MA56416A (cg-RX-API-DMAC7.html) |
| PL (1) | PL3294775T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016183222A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121253411A (zh) | 2015-11-30 | 2026-01-02 | 因塔生物有限责任公司 | 用于样品表征的装置和方法 |
| CN109937034B (zh) | 2016-11-21 | 2022-09-16 | 济世-伊沃泰克生物制品有限公司 | 阿柏西普制剂及其用途 |
| MY199833A (en) | 2017-08-17 | 2023-11-24 | Just Evotec Biologics Inc | Method of purifying glycosylated protein from host cell galectins and other contaminants |
| MY202872A (en) | 2017-11-20 | 2024-05-28 | Just Evotec Biologics Inc | Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof |
| CA3089842A1 (en) | 2018-01-29 | 2019-08-01 | Intabio, Inc. | Devices, methods and kits for sample characterization |
| EP3811397B1 (en) | 2018-05-31 | 2024-09-18 | Intabio, Llc | Methods for interfacing microfluidic systems with mass spectrometry |
| WO2020055832A1 (en) * | 2018-09-10 | 2020-03-19 | Genentech, Inc. | Systems and methods for affinity capillary electrophoresis |
| US11782023B2 (en) * | 2018-12-19 | 2023-10-10 | Regeneron Pharmaceuticals, Inc. | Ce-western applications for antibody development |
| CA3126712A1 (en) * | 2019-01-31 | 2020-08-06 | Regeneron Pharmaceuticals, Inc. | Native microfluidic ce-ms analysis of antibody charge heterogeneity |
| US12594557B2 (en) | 2019-08-12 | 2026-04-07 | Intabio, Llc | Isoelectric focusing devices and fixtures |
| US11285484B2 (en) | 2019-08-12 | 2022-03-29 | Intabio, Llc | Multichannel isoelectric focusing devices and high voltage power supplies |
| JP2024513950A (ja) * | 2021-04-14 | 2024-03-27 | ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド | キャピラリー電気泳動におけるタンパク質分析のための天然蛍光検出 |
| CN118284809A (zh) * | 2021-11-25 | 2024-07-02 | 豪夫迈·罗氏有限公司 | 少量抗体副产物的定量 |
| WO2024123698A1 (en) * | 2022-12-08 | 2024-06-13 | Regeneron Pharmaceuticals, Inc. | Methods to characterizing a fragment crystallizable domain of a bispecific antibody |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP385598A0 (en) * | 1998-06-02 | 1998-06-25 | Life Therapeutics Limited | Purification of antibodies |
| US6472179B2 (en) * | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
| US6818112B2 (en) * | 1999-04-20 | 2004-11-16 | Target Discovery, Inc. | Protein separation via multidimensional electrophoresis |
| JP4723725B2 (ja) * | 1999-04-20 | 2011-07-13 | ターゲット ディスカバリー, インコーポレイテッド | 代謝経路を分析するための方法 |
| US7087411B2 (en) | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| AUPQ743300A0 (en) * | 2000-05-11 | 2000-06-01 | Life Therapeutics Limited | Separation of avian antibodies |
| US6927004B2 (en) | 2002-03-08 | 2005-08-09 | Asml Netherlands B.V. | Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method |
| WO2007034907A1 (ja) * | 2005-09-22 | 2007-03-29 | Chemicals Evaluation And Research Institute | 被検化学物質の生物に与える影響の予測方法 |
| EP1803814A1 (en) * | 2005-12-27 | 2007-07-04 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Method of improving the antibody selection capacity in phage-display library |
| JP5144499B2 (ja) * | 2006-03-31 | 2013-02-13 | 中外製薬株式会社 | 二重特異性抗体を精製するための抗体改変方法 |
| DK2150617T3 (en) | 2007-06-04 | 2015-01-12 | Regeneron Pharma | Regions with increased expression and stability |
| EP3127921A1 (en) * | 2007-09-26 | 2017-02-08 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substition in cdr |
| JP4977588B2 (ja) * | 2007-12-07 | 2012-07-18 | 富士フイルム株式会社 | イムノクロマトグラフ方法 |
| TWI507525B (zh) | 2009-06-26 | 2015-11-11 | Regeneron Pharma | 具天然免疫球蛋白形式之易分離的雙專一性抗體 |
| US9376495B2 (en) * | 2011-05-21 | 2016-06-28 | Macrogenics, Inc. | Deimmunized serum-binding domains and their use in extending serum half-life |
| GB2504139B (en) * | 2012-07-20 | 2014-12-31 | Argen X Bv | Antibodies to highly conserved targets produced by the immunisation of Camelidae species |
| EP2604624A1 (en) * | 2011-12-13 | 2013-06-19 | University College Dublin National University Of Ireland, Dublin | Bowman-Birk protease Inhibitor (BBI) binding peptides, and uses thereof in the separation, detection or purification of BBI. |
| EP3517548A1 (en) * | 2012-03-13 | 2019-07-31 | NovImmune S.A. | Readily isolated bispecific antibodies with native immunoglobulin format |
| SG10201609535TA (en) | 2012-06-05 | 2017-01-27 | Regeneron Pharma | Methods for making fully human bispecific antibodies using a common light chain |
| TWI864338B (zh) | 2012-11-14 | 2024-12-01 | 美商再生元醫藥公司 | 重組細胞表面捕捉蛋白質 |
| CN118271429A (zh) * | 2013-08-19 | 2024-07-02 | 豪夫迈·罗氏有限公司 | 用羟基磷灰石层析分离双特异性抗体和双特异性抗体生产副产物 |
| EP3041865A2 (en) * | 2013-09-03 | 2016-07-13 | NovImmune S.A. | Readily isolated bispecific binding molecules with native format having mutated constant regions |
-
2016
- 2016-05-11 EP EP16724805.3A patent/EP3294775B1/en active Active
- 2016-05-11 ES ES16724805T patent/ES2881359T3/es active Active
- 2016-05-11 JP JP2017558949A patent/JP7240812B2/ja active Active
- 2016-05-11 AU AU2016261854A patent/AU2016261854B2/en active Active
- 2016-05-11 WO PCT/US2016/031899 patent/WO2016183222A1/en not_active Ceased
- 2016-05-11 US US15/152,135 patent/US10520511B2/en active Active
- 2016-05-11 CA CA2984010A patent/CA2984010A1/en active Pending
- 2016-05-11 EP EP21171963.8A patent/EP3885368A1/en not_active Withdrawn
- 2016-05-11 MA MA056416A patent/MA56416A/fr unknown
- 2016-05-11 PL PL16724805T patent/PL3294775T3/pl unknown
- 2016-05-11 MA MA043987A patent/MA43987A/fr unknown
- 2016-05-12 AR ARP160101379A patent/AR104610A1/es unknown
-
2019
- 2019-11-18 US US16/686,770 patent/US12158473B2/en active Active
-
2021
- 2021-06-02 JP JP2021092988A patent/JP7137663B2/ja not_active Expired - Fee Related
-
2022
- 2022-05-05 AU AU2022203033A patent/AU2022203033B2/en not_active Expired - Fee Related
- 2022-09-02 JP JP2022139802A patent/JP2022171730A/ja active Pending
-
2024
- 2024-04-16 US US18/637,343 patent/US20240280587A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018528389A5 (cg-RX-API-DMAC7.html) | ||
| JP7137663B2 (ja) | 多量体タンパク質の純度の決定 | |
| JP2021152544A6 (ja) | 多量体タンパク質の純度の決定 | |
| JP2022171730A5 (cg-RX-API-DMAC7.html) | ||
| JP2021515798A5 (cg-RX-API-DMAC7.html) | ||
| JP2018520127A5 (cg-RX-API-DMAC7.html) | ||
| TWI850255B (zh) | 用於親和毛細管電泳之系統及方法 | |
| WO2024225979A1 (en) | Anti il-11 antibody | |
| JP6157862B2 (ja) | 標的物質−レセプター複合体と遊離レセプターとを分離する方法 | |
| HK40059237A (en) | Multimeric protein purity determination | |
| HK40050332A (en) | Systems and methods for affinity capillary electrophoresis | |
| HK40045222B (en) | Systems and methods for affinity capillary electrophoresis | |
| HK40045222A (en) | Systems and methods for affinity capillary electrophoresis | |
| HK1252480B (en) | Multimeric protein purity determination |